Table 1.
Characteristics of the patients at the baseline. * indicates statistically significant p values.
| FOLFIRINOX (n = 35) |
Gemcitabine NabPaclitaxel (n = 21) |
p | |
|---|---|---|---|
| Median Age years (range) | 59.2 (42–70) | 65.4 (44–79) | 0.042 * |
| Male/Female | 17/18 | 13/8 | 0.12 |
| Site (n): | |||
| Head Body/Tail |
20 15 |
16 5 |
0.46 |
| PS ECOG: | |||
| 0 1 |
30 5 |
17 9 |
0.007 * |
| Median CA19.9 UI/mL at diagnosis (range) | 841.95 (1–10694) |
2125.58 (0.8–18801) |
0.20 |
| T classification: | |||
| T4 T3 |
27 8 |
19 2 |
0.96 |
| N classification: | |||
| N0 N+ |
14 21 |
7 14 |
0.34 |